Cakal E - Search Results

1

The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism.

Serter R, Demirbas B, Korukluoglu B, Culha C, Cakal E, Aral Y. Serter R, et al. Among authors: cakal e. J Endocrinol Invest. 2004 Nov;27(10):897-903. doi: 10.1007/BF03347530. J Endocrinol Invest. 2004. PMID: 15762035 Clinical Trial.

2

Plasma homocysteine levels in hyperthyroid patients.

Demirbas B, Ozkaya M, Cakal E, Culha C, Gulcelik N, Koc G, Serter R, Aral Y. Demirbas B, et al. Among authors: cakal e. Endocr J. 2004 Feb;51(1):121-5. doi: 10.1507/endocrj.51.121. Endocr J. 2004. PMID: 15004418 Free article.

3

Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy.

Gulcelik NE, Kaya E, Demirbas B, Culha C, Koc G, Ozkaya M, Cakal E, Serter R, Aral Y. Gulcelik NE, et al. Among authors: cakal e. J Endocrinol Invest. 2005 Mar;28(3):214-7. doi: 10.1007/BF03345375. J Endocrinol Invest. 2005. PMID: 15952404

4

The effect of ursodeoxycholic acid treatment on epidermal growth factor in patients with bile reflux gastritis.

Ozkaya M, Erten A, Sahin I, Engin B, Ciftçi A, Cakal E, Caydere M, Demirbaş B, Ustün H. Ozkaya M, et al. Among authors: cakal e. Turk J Gastroenterol. 2002 Dec;13(4):198-202. Turk J Gastroenterol. 2002. PMID: 16378305 Free article.

5

Homocysteine and fibrinogen changes with L-thyroxine in subclinical hypothyroid patients.

Cakal B, Cakal E, Demirbaş B, Ozkaya M, Karaahmetoğlu S, Serter R, Aral Y. Cakal B, et al. Among authors: cakal e. J Korean Med Sci. 2007 Jun;22(3):431-5. doi: 10.3346/jkms.2007.22.3.431. J Korean Med Sci. 2007. PMID: 17596649 Free PMC article.

6

Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism.

Cakal E, Turgut AT, Demirbas B, Ozkaya M, Cakal B, Serter R, Aral Y. Cakal E, et al. Among authors: cakal b. Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):294-300. doi: 10.1055/s-0028-1085998. Epub 2008 Sep 30. Exp Clin Endocrinol Diabetes. 2009. PMID: 19085705

7

Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function.

Ozkaya M, Sahin M, Cakal E, Yuzbasioglu F, Sezer K, Kilinc M, Imrek SS. Ozkaya M, et al. Among authors: cakal e. J Endocrinol Invest. 2009 May;32(5):435-9. doi: 10.1007/BF03346482. Epub 2009 May 15. J Endocrinol Invest. 2009. PMID: 19498324 Clinical Trial.

8

Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome.

Cakal E, Ozkaya M, Engin-Ustun Y, Ustun Y. Cakal E, et al. J Endocrinol Invest. 2011 Feb;34(2):97-100. doi: 10.1007/BF03347037. Epub 2010 May 28. J Endocrinol Invest. 2011. PMID: 20511727

9

Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients.

Cakir E, Ozbek M, Ozkaya E, Colak N, Cakal E, Sayki M, Gungunes A, Aliyazicioglu Y, Mentese A, Delibasi T. Cakir E, et al. Among authors: cakal e. J Endocrinol Invest. 2011 Jul-Aug;34(7):e178-82. doi: 10.3275/7352. Epub 2010 Nov 16. J Endocrinol Invest. 2011. PMID: 21088474

10

Cardiovascular risk factors, carotid artery intima media thickness, and HSCRP levels in patients with impaired glucose metabolism.

Karbek B, Cakal E, Cakir E, Bozkurt N, Unsal I, Sahin M, Delibaşi T. Karbek B, et al. Among authors: cakal e. Minerva Endocrinol. 2013 Sep;38(3):297-304. Minerva Endocrinol. 2013. PMID: 24126550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters